Insights & Thought Pieces:
The Rise of Early Onset Colorectal Cancer
Aug. 12, 2024 – Recently, the FDA approved the first-ever blood test for colorectal cancer screening for adults of average cancer risk. Although there are still several limitations, this approval comes at a crucial time, as researchers grapple with the rising incidence of early-onset colorectal cancer (EOCRC). In this white paper, API’s Thiviya Jeyakumar summarizes the latest in EOCRC trends and CRC screening methods.
Sickle Cell Disease: White Paper
Sep 30, 2024 – September is Sickle Cell Disease Awareness Month! As the month draws to a close, API’s James Perry reviews recent developments in the field and the future of SCD therapies. Despite striking advancements, including recent approvals of potentially curative treatments, current therapies are vastly underutilized. Improving access to care is a necessary first step before novel, more convenient treatments become available. Read through James’ white paper below!